Kallik to sponsor Pharmaceutical and Device Packaging and Labelling in September.

Kallik to sponsor Pharmaceutical and Device Packaging and Labelling in September. Kallik is set to sponsor and speak at Pharmaceutical and Device Packaging and Labelling (PHPL) conference in Munich on 10th and 11th September 2019. Ashley Goldie, Kallik’s Managing Director will be presenting at the event, which attracts pharma and biotech experts from across Europe….


Lightning-fast search results to identify labels impacted by change.

New lightning-fast search results to identify labels impacted by change. Kallik has launched an update to its AMS360 solution. AMS360 Release 6, that will transform the experience of the business user, whilst defining new benchmarks for speed, accuracy, and efficiency of global labelling and artwork processes. More complex and competitive marketplaces, weaker margins, and increasing…


Is your medical device organisation on track to comply with the EU MDR?

With May 2020 just over one year away, the clock is ticking on the need to ensure compliance with the EU Medical Device Regulation (EU MDR). The new regulations can be seen as not only a requirement, but a method of survival for medical device organisations, with key implications on product and package labelling. What…


Expert insights: preparing for the ongoing uncertainty around Brexit outcomes

What are the immediate and long-term impacts of Brexit on labelling, and how can medical device and pharmaceutical organisations be better prepared? Kallik’s New Business Development Manager, Richard Castle shares his thoughts:   Be better prepared for the ongoing uncertainty around Brexit outcomes. Get in touch with Richard to learn more.



Expert insights: ensuring your artwork is compliant with EU MDR

Adopting a joined-up, cloud-based labelling and artwork management solution is a key way to ensure an organisation is prepared to manage the EU MDR’s regulation and compliance changes in a more efficient manner. Bob Tilling, New Business Development Manager at Kallik provides expert insight into how adopting this solution can help you plan and prepare…


EU MDR: an opportunity or a hindrance?

With the EU MDR looming, medical device organisations have an opportunity to improve organisation-wide best practice, rather than seeing achieving compliance as a short-term business overhead. Enforced compliance such as this gives medical device organisations the chance to organise and cleanse their labelling data and in turn create downstream value now rather than later. Many…


EU MDR: preparing for the key changes

Understanding the EU MDR Europe’s medical device regulations are changing, bringing about some of the most substantial shifts to the ways in which manufacturers bring their devices into the EU market, and how compliance must be maintained throughout the product lifecycle. The regulations strive to increase the traceability and safety of medical devices in the…


Brexit – deal or no deal for labelling?

The time for the UK to leave the EU is fast approaching. With March 29th 2019 the official date. The post-Brexit transition period is in fact set to run until December 31st 2020, meaning the chances are very high that the UK-EU relationship will be staying the same until then, but two years in the…


Playing by the rules: avoiding process roadblocks with business rules

Keeping up with changing regulations Notwithstanding the upcoming implementation of the new EU MDR in May 2020, many organisations in the medical devices, pharmaceutical, chemicals and cosmetics industries are experiencing unprecedented demands from regulatory authorities and consumers alike. Product labelling must be clearer, more informative and published electronically in addition to print. It must also…